Latest news with #UltraClear
Elle
30-06-2025
- Health
- Elle
How New Laser Treatments Are Transforming Skin Tightening—With Less Pain and Downtime
Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. You're sitting in a doctor's office with numbing cream spread on your face like buttercream icing on a cake. You're preparing to have a laser beam penetrate your skin at the same temperature that water boils. You're bracing for your face to resemble tuna tartare for at least a week. Sounds scary? For a long time, this may have been the reality for anyone seeking a laser treatment to tighten or tone skin. Today's lasers, however, are far less harsh, reducing pain and downtime for many patients—and might be even more effective for lifting and brightening. These next-gen options are also safer across skin tones. 'A lot of [older lasers] readily absorb melanin, so [people with darker complexions] can get really significant burns,' says Michelle Henry, MD, a dermatologist in New York. Now, many of the lasers she currently has in her office are safe for dark skin. Perhaps as a result, lasers are booming: There were over 3.5 million skin resurfacing procedures in 2023, a 5 percent increase over 2022, according to the American Society of Plastic Surgeons' annual statistics report. Here are some of the best lasers that don't belong in a sequel to The Substance. According to Eunice Park, MD, a facial plastic surgeon in New York, a method called 'Pico Sculpting,' which is popular in South Korea to tighten skin, is gaining ground in the U.S. Using super-short pulses of energy at different depths, the picosecond laser can target its effects: It can plunge to deep levels, like a scuba diver, to tighten without disturbing the outermost layer. It can sweep through the middle layers, like a snorkeler, to rejuvenate. And it can skim the surface, like a surfer, to smooth texture. Though skin might be slightly red or swollen for a few days, the minimal downtime unveils results starting within a week. Ablative lasers are a great tool for resurfacing, but they can also make you look sunburned for up to a month. UltraClear is the first cold fiber ablative laser that stimulates collagen without causing excessive redness. ('Cold' doesn't refer to a temperature, but rather for the way the laser uses a unique 2,910-nanometer wavelength to treat the skin, according to Arielle Kauvar, MD, a dermatologist in New York City.) UltraClear delivers quick pulses of energy in intervals to curtail heat damage and pain. Unlike other ablative lasers, UltraClear's 3DMiracl treatment seldom requires any numbing cream beforehand and has less downtime, though there may be a bit of redness or swelling. Patients can notice skin improvements within five days. Mosaic 3D works well for hyperpigmentation, acne scarring, and wrinkles. It's a non-ablative laser (meaning it doesn't disturb the skin's surface), which Henry says makes it ideal for all skin tones. But precision is what makes this laser a secret weapon: It has a cold sapphire tip for chilling the skin; an air-cooled rolling system for even coverage; and an algorithm called 3D Controlled Chaos Technology to control the space and depth of where beams enter the skin. These features allow the laser to sweep over tricky-to-reach areas, like around the eyes and mouth. Skin may be mildly red for up to 48 hours, but downtime is only two to five days. A version of this story appears in the April 2025 issue of ELLE. GET THE LATEST ISSUE OF ELLE
Cision Canada
25-06-2025
- Business
- Cision Canada
Acclaro Medical Receives Health Canada Approval for UltraClear® 2910 nm Cold Ablative Fiber Laser
~ Groundbreaking Laser Featuring Superficial 3DMIRACL ® and First-of-its-Kind Laser Coring ™ ~ Acclaro Medical Partners with Xcite Technology, North America's Leading Provider of Revolutionary Energy-Based Skin Technologies, to Drive Canadian Distribution Efforts SMITHFIELD, R.I., June 25, 2025 /CNW/ -- Acclaro Medical, a global innovator in advanced energy-based technologies for aesthetic, ophthalmic and surgical markets, is proud to announce the approval of its flagship UltraClear ® 2910 nm fiber laser by Health Canada. This clearance marks a significant expansion for the company and brings one of the industry's most advanced skin rejuvenation platforms to Canadian provider and patients. Acclaro Medical has also partnered with Xcite Technology, a recognized leader in aesthetic energy-based device distribution, to spearhead commercialization efforts across Canada. Engineered with proprietary MID IR Fiber Laser and 3DIntelliPulse™ technology, UltraClear is the world's first and only 2910 nm cold ablative fiber offering precise, customizable treatments that address superficial to deep skin concerns with minimal downtime and exceptional patient comfort. Its unique treatment modes, including 3DMIRACL ® for gentle resurfacing and Laser Coring™ to help reverse a wide range of telltale signs associated with aging and gravity, set a new standard for what's possible in total skin health. "The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients," said Helen Fang, CEO, Acclaro Medical. "Across Acclaro Medical, we are proud of our shared vision to deliver category-defining solutions for a full range of patient-friendly treatment options tailored to their needs, lifestyles and skin types." As the exclusive Canadian distributor, Xcite Technologies will bring UltraClear to aesthetic clinics nationwide. With a strong track record in introducing disruptive technologies to the market, Xcite is ideally positioned to support clinical adoption and elevate standards in laser-based treatments. "UltraClear is unlike anything currently available," said Bill Roberts, CEO of Xcite Technologies. "The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision, depth, and patient comfort that truly redefines what's possible in skin rejuvenation. This is a major step forward for Canadian providers looking to offer high-efficacy treatments with minimal downtime and broad patient appeal." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL ® and Laser Coring ® skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit or contact Xcite Technologies for regional availability. Xcite Technologies is Canada's leading distributor of advanced medical aesthetic technologies, known for bringing the most innovative, clinically proven aesthetic solutions. With a consistent track record of launching state-of-the-art platforms like UltraClear, Xcite remains at the forefront of aesthetic medicine—ensuring Canadian providers have access to the latest global advancements in energy-based treatments that address the full spectrum of skin types and concerns.
Yahoo
25-06-2025
- Business
- Yahoo
Acclaro Medical Receives Health Canada Approval for UltraClear® 2910 nm Cold Ablative Fiber Laser
~ Groundbreaking Laser Featuring Superficial 3DMIRACL® and First-of-its-Kind Laser Coring™ Treatments Now Available in Canada ~ Acclaro Medical Partners with Xcite Technology, North America's Leading Provider of Revolutionary Energy-Based Skin Technologies, to Drive Canadian Distribution Efforts SMITHFIELD, R.I., June 25, 2025 /CNW/ -- Acclaro Medical, a global innovator in advanced energy-based technologies for aesthetic, ophthalmic and surgical markets, is proud to announce the approval of its flagship UltraClear® 2910 nm fiber laser by Health Canada. This clearance marks a significant expansion for the company and brings one of the industry's most advanced skin rejuvenation platforms to Canadian provider and patients. Acclaro Medical has also partnered with Xcite Technology, a recognized leader in aesthetic energy-based device distribution, to spearhead commercialization efforts across Canada. Engineered with proprietary MID IR Fiber Laser and 3DIntelliPulse™ technology, UltraClear is the world's first and only 2910 nm cold ablative fiber offering precise, customizable treatments that address superficial to deep skin concerns with minimal downtime and exceptional patient comfort. Its unique treatment modes, including 3DMIRACL® for gentle resurfacing and Laser Coring™ to help reverse a wide range of telltale signs associated with aging and gravity, set a new standard for what's possible in total skin health. "The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients," said Helen Fang, CEO, Acclaro Medical. "Across Acclaro Medical, we are proud of our shared vision to deliver category-defining solutions for a full range of patient-friendly treatment options tailored to their needs, lifestyles and skin types." As the exclusive Canadian distributor, Xcite Technologies will bring UltraClear to aesthetic clinics nationwide. With a strong track record in introducing disruptive technologies to the market, Xcite is ideally positioned to support clinical adoption and elevate standards in laser-based treatments. "UltraClear is unlike anything currently available," said Bill Roberts, CEO of Xcite Technologies. "The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision, depth, and patient comfort that truly redefines what's possible in skin rejuvenation. This is a major step forward for Canadian providers looking to offer high-efficacy treatments with minimal downtime and broad patient appeal." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL® and Laser Coring® skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit or contact Xcite Technologies for regional availability. About Xcite Technologies Xcite Technologies is Canada's leading distributor of advanced medical aesthetic technologies, known for bringing the most innovative, clinically proven aesthetic solutions. With a consistent track record of launching state-of-the-art platforms like UltraClear, Xcite remains at the forefront of aesthetic medicine—ensuring Canadian providers have access to the latest global advancements in energy-based treatments that address the full spectrum of skin types and concerns. Media Contact:Nadine ToskTosk Communications for Acclaro Medicalnadinepr@ 504.453.8344 View original content to download multimedia: SOURCE Acclaro Corporation View original content to download multimedia:
Yahoo
17-06-2025
- Health
- Yahoo
Top Salt Lake City Oculoplastic Surgeon, Dr. Kian Eftekhari, Introduces the UltraClear® Laser, A New Standard in Under-Eye Rejuvenation and Skin Resurfacing
Dr. Kian Eftekhari Adds UltraClear® Laser to Eyelid Center of Utah, Offering Advanced Treatment for Fine Under-Eye Wrinkles and Skin Rejuvenation. SALT LAKE CITY, June 17, 2025 /PRNewswire/ -- Renowned oculofacial plastic surgeon Dr. Kian Eftekhari is proud to announce the addition of the UltraClear® laser to the advanced treatment offerings at the Eyelid Center of Utah. As one of the first specialists in the region to invest in this cutting-edge technology, Dr. Eftekhari continues to lead the way in delivering safe, innovative, and effective aesthetic solutions for the delicate areas of the face—especially around the eyes. The UltraClear® laser is a next-generation, cold fiber laser platform that utilizes 3DIntelliPulse™ technology to deliver unparalleled precision in skin resurfacing. Unlike traditional lasers that rely on heat-based ablation, UltraClear uses a cold ablative approach that minimizes thermal damage to surrounding tissues. This allows for faster healing, minimal downtime, and highly effective results. Of particular importance to Dr. Eftekhari's patients, UltraClear is exceptionally effective at treating fine wrinkles under the eyes, an area that is notoriously difficult to rejuvenate with standard laser technology. The platform's laser coring capabilities precisely target and stimulate collagen remodeling in this delicate region—providing smoother, firmer skin and a more youthful appearance without surgical intervention. "I'm excited to offer UltraClear to my patients because it allows me to safely and effectively treat under-eye wrinkles and sun damage with minimal downtime," said Dr. Eftekhari. "The precision of this laser is unmatched, especially in delicate areas like the eyelids. It's the perfect complement to my surgical and non-surgical eyelid procedures." In addition to under-eye rejuvenation, UltraClear is ideal for: Full-face skin resurfacing Sun damage and hyperpigmentation Fine lines and deep wrinkles Acne scars and textural irregularities Pore size reduction and skin smoothing Because UltraClear treatments are fast and require little to no downtime, they are a popular option for patients seeking noticeable results without extended recovery periods. Treatments can be customized for different skin types and depths, making it a highly versatile tool in Dr. Eftekhari's practice. As a board-certified eye surgeon specializing in oculofacial plastic surgery, Dr. Kian Eftekhari is uniquely qualified to use laser technology in sensitive facial areas. His training and surgical expertise ensure the highest level of precision and safety when treating the delicate skin around the eyes and face. About Dr. Kian Eftekhari and the Eyelid Center of UtahDr. Kian Eftekhari is a nationally recognized expert in eyelid and facial plastic surgery. Board-certified and fellowship-trained, he specializes in both aesthetic and reconstructive procedures including eyelid lifts, brow lifts, eyelid cancer reconstruction, thyroid eye disease treatment, and facial paralysis surgery. His Salt Lake City-based practice, Eyelid Center of Utah, is dedicated exclusively to eyelid and facial procedures, offering patients expert-level care and tailored treatment plans. To learn more about UltraClear® laser treatments or to schedule a consultation, please visit or call the office directly. Media Contact:Kian Eftekhari MDEyelid Center of Utah801-685-3398https:// View original content to download multimedia: SOURCE Eyelid Center of Utah Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-05-2025
- Business
- Yahoo
Acclaro Medical secures $23m in Series B funding for skin laser technologies
Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear and AuraLux, and facilitate the company's global market expansion. Accelmed Partners spearheaded the funding round, which also received support from the current investor, 3E Bioventures Capital. Acclaro Medical co-founder and CEO Helen Fang said: "This funding empowers us to continue our strong growth and realise our vision of improving the quality of life for people of all skin colours and all ages worldwide." UltraClear comprises a 2,910nm cold ablative fibre laser that leverages 3DIntelliPulse technology and offers enhanced safety across all types of skin. Cleared by the US Food and Drug Administration (FDA), UltraClear operates by vaporising the skin's damaged outer layers and heating the underlying layers with controlled thermal energy, promoting the growth of new cells and boosting elastin and collagen production. According to Acclaro Medical, the laser's cold beams aid in the removal of damaged epidermal cells, reducing side effects and pain. Its beam quality facilitates consistent resurfacing outcomes, akin to an advanced form of exfoliation. Alongside UltraClear, the company's AuraLux laser utilises the exclusive Cool Pulse technology. This expansion of the product line aims to enhance accessibility for providers and their patients. Acclaro Medical co-founder and president Shlomo Assa said: "We are thrilled to have the support of Accelmed as we expand our global and domestic footprint. This Series B funding is a strong vote of confidence in our mission to bring UltraClear and AuraLux to more people pursuing anti-ageing solutions for healthier and younger-looking skin. 'It greatly enables us to accelerate product development, expand our team, and reach more customers globally." In 2022, Acclaro Corporation introduced the UltraClear laser technology system in the US. "Acclaro Medical secures $23m in Series B funding for skin laser technologies" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
